AxoGen Inc
NASDAQ:AXGN
Gross Margin
AxoGen Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
AxoGen Inc
NASDAQ:AXGN
|
714.3m USD |
76%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
224.3B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.1B USD |
67%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
150.7B USD |
69%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
139.8B USD |
64%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.8B USD |
66%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.8B EUR |
38%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.3B USD |
45%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.5B USD |
79%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.4B USD |
61%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.7B CNY |
64%
|
AxoGen Inc
Glance View
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on AxoGen Inc's most recent financial statements, the company has Gross Margin of 75.8%.
You don't have any saved screeners yet